5Yang W Y,Li G W,Liu J,et a1. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,(10):1090-1101. 被引量：1
6Spitz AF, Kanani H. Change in HbAiC as a measure of quality ofdiabetes care[j]. Diabetes Care, 2006, 29(5): 1183-1184. 被引量：1
7Turner RC, Holman RR, Cull CA, et al. Intensive blood-glucosecontrol with sulphonylureas or insulin compared with conventionaltreatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J]. Lancet, 1998, 352(9131): 837-853. 被引量：1
8Giugliano D,Maiorino MI,Bellastella G, et al. Efficacy of insulinanalogs in achieving the hemoglobin Ale target of < 7% in type 2diabetes : meta-analysis of randomized controlled trials [ J ]. DiabetesCare, 2011, 34(2); 510-517. 被引量：1
9American Diabetes Association. Standards of medical care indiabetes—2013[j]. Diabetes Care, 2013, 36 Suppl 1 : SI 1-66. 被引量：1
10Ning G, Bloomgarden Z. Diabetes in China: prevalence,diagnosis, and control [j]. J Diabetes, 2013, 5(4): 372. 被引量：1
